By Rishika Sadam and Kashish Tandon
HYDERABAD, India, Feb 26 (Reuters) - Drugmaker Merck MRK.N, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the end of the year, a senior company executive said on Wednesday.
"By the end of this year, we expect to have roughly 2,700 employees. And in a couple of years, I fully expect we'll double that number or more," Executive Vice President Dave Williams said at the BioAsia conference in India's Telangana state.
Merck's India sites, which together employ around 1,800 people, focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as technology-related centers.
The U.S. drugmaker opened a new technology center in the southern Indian city of Hyderabad this week.
Williams, who heads the information and digital department, said the company is looking to hire "digital innovators" who can help business partners understand the role technology can play in reducing the time taken to get new treatments to patients.
(Reporting by Rishika Sadam and Kashish Tandon in Hyderabad; Writing by Mariam Sunny in Bengaluru; Editing by Sriraj Kalluvila)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.